High-resolution Crystal Structure of Dimeric VP40 from Sudan ebolavirus

Journal of Infectious Diseases

Volumn 212, Issue , 2015, Pages S167-S171

  Clifton, Matthew C ^a,d   Bruhn, Jessica F ^e   Atkins, Kateri ^a,d   Webb, Terry L ^a,c   Baydo, Ruth O ^a,c   Raymond, Amy ^a,c   Lorimer, Donald D ^a,c   Edwards, Thomas E ^a,c   Myler, Peter J ^a,b   Saphire, Erica Ollmann ^e,f  

^a Seattle Structural Genomics Center for Infectious Disease   (United States)

^b SEATTLE BIOMEDICAL RESEARCH INSTITUTE   (United States)

^c Beryllium   (United States)

^d Beryllium   (United States)

^e Scripps Research Institute ^*  (United States)

^f SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Ebola virus; matrix protein; Sudan ebolavirus; virus budding; VP40

Indexed keywords

PROTEIN VP40; MATRIX PROTEIN; SOLUTION AND SOLUBILITY; VP40 PROTEIN, VIRUS;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CLONING; CRYSTAL STRUCTURE; DIMERIZATION; EBOLAVIRUS; FLUOROMETRY; LIGHT SCATTERING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PURIFICATION; SIZE EXCLUSION CHROMATOGRAPHY; SUDAN EBOLAVIRUS; TRANSCRIPTION REGULATION; VIRUS ASSEMBLY; VIRUS REPLICATION; CHEMISTRY; ESCHERICHIA COLI; METABOLISM; PHYSIOLOGY; PROTEIN MULTIMERIZATION; PROTEIN TERTIARY STRUCTURE; SOLUTION AND SOLUBILITY; SUDAN;

EBOLAVIRUS; ESCHERICHIA COLI; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, TERTIARY; SOLUTIONS; SUDAN; VIRAL MATRIX PROTEINS;

EID: 84943252550     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv090     Document Type: Article

References (14)

1. Burke J, Declerq R, Ghysebrechts G, et al. Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ 1978; 56:271-93.
2. Kuhn JH, Dodd LE, Wahl-Jensen V, Radoshitzky SR, Bavari S, Jahrling PB. Evaluation of perceived threat differences posed by filovirus variants. Biosecur Bioterr 2011; 9:361-71.
3. Harty RN, Brown ME, Wang G, Huibregtse J, Hayes FP. A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding. Proc Natl Acad Sci U S A 2000; 97:13871-6.
4. Panchal RG, Ruthel G, Kenny TA, et al. In vivo oligomerization and raft localization of Ebola virus protein VP40 during vesicular budding. Proc Natl Acad Sci U S A 2003; 100:15936-41.
5. Geisbert TW, Jahrling PB. Differentiation of filoviruses by electron microscopy. Virus Res 1995; 39:129-50.
6. Johnson RF, Bell P, Harty RN. Effect of Ebola virus proteins GP, NP and VP35 on VP40 VLP morphology. Virology J 2006; 3:31.
7. Noda T, Sagara H, Suzuki E, Takada A, Kida H, Kawaoka Y. Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP. J Virol 2002; 76:4855-65.
8. Hoenen T, Jung S, Herwig A, Groseth A, Becker S. Both matrix proteins of Ebola virus contribute to the regulation of viral genome replication and transcription. Virology 2010; 403:56-66.
9. Gomis-Ruth FX, Dessen A, Timmins J, et al. The matrix protein VP40 from Ebola virus octamerizes into pore-like structures with specific RNA binding properties. Structure 2003; 11:423-33.
10. Bornholdt ZA, Noda T, Abelson DM, et al. Structural rearrangement of Ebola virus VP40 begets multiple functions in the virus life cycle. Cell 2013; 154:763-74.
11. Hoenen T, Biedenkopf N, Zielecki F, et al. Oligomerization of Ebola virus VP40 is essential for particle morphogenesis and regulation of viral transcription. J Virology 2010; 84:7053-63.
12. Dessen A, Volchkov V, Dolnik O, Klenk HD, Weissenhorn W. Crystal structure of the matrix protein VP40 from Ebola virus. EMBO J 2000; 19:4228-36.
13. Krissinel E, Henrick K. Inference of macromolecular assemblies from crystalline state. J Mol Biol 2007; 372:774-97.
14. Stahelin RV. Could the Ebola virus matrix protein VP40 be a drug target? Expert Opin Ther Targets 2014; 18:115-20.